Close Menu
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    StockNews24StockNews24
    Subscribe
    • Shares
    • News
      • Featured Company
      • News Overview
        • Company news
        • Expert Columns
        • Germany
        • USA
        • Price movements
        • Default values
        • Small caps
        • Business
      • News Search
        • Stock News
        • CFD News
        • Foreign exchange news
        • ETF News
        • Money, Career & Lifestyle News
      • Index News
        • DAX News
        • MDAX News
        • TecDAX News
        • Dow Jones News
        • Eurostoxx News
        • NASDAQ News
        • ATX News
        • S&P 500 News
      • Other Topics
        • Private Finance News
        • Commodity News
        • Certificate News
        • Interest rate news
        • SMI News
        • Nikkei 225 News1
    • Carbon Markets
    • Raw materials
    • Funds
    • Bonds
    • Currency
    • Crypto
    • English
      • العربية
      • 简体中文
      • Nederlands
      • English
      • Français
      • Deutsch
      • Italiano
      • Português
      • Русский
      • Español
    StockNews24StockNews24
    Home » Inquiry into British woman’s 2018 Novichok poisoning to start By Reuters
    News

    Inquiry into British woman’s 2018 Novichok poisoning to start By Reuters

    userBy userOctober 13, 2024No Comments2 Mins Read
    Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Email


    By Michael Holden

    LONDON (Reuters) – A public inquiry into the death of a woman who Britain says was unwittingly killed by the Novichok nerve agent following the attempted murder of former Russian double agent Sergei Skripal six years ago will begin on Monday.

    Dawn Sturgess died from exposure to Novichok in July 2018 after her partner found a counterfeit perfume bottle which police believe had been used by Russian intelligence operatives to smuggle the poison into the country.

    Skripal, who sold Russian secrets to Britain, and his daughter Yulia had been found slumped unconscious on a public bench in the southern English city of Salisbury four months earlier. 

    Both they, and a police officer who went to Skripal’s house, were left critically ill from the effects of the military-grade nerve agent, but recovered.

    On Monday, an inquiry into Sturgess’s death finally opens, with hearings held initially in Salisbury. Its aim is to provide her family with answers to how her death came about, and it will hear some confidential evidence in secret from the government and the security services.

    While British police have charged in absentia three Russians, who they say are GRU military intelligence officers, over the attack on Skripal and his daughter, no formal case has been brought against them over the death of Sturgess, 44.

    The three men and Moscow have denied any involvement.

    Last month, the inquiry chair, former Supreme Court judge Anthony Hughes, ruled that the Skripals would not give evidence themselves, saying there was an “overwhelming risk” they still faced physical attack if they could be identified and their current whereabouts revealed.

    Two of the Russians accused by Britain of carrying out the poisoning later appeared on Russian TV to deny involvement, saying they had been innocent tourists visiting the city’s cathedral.

    The incident led to the biggest East-West diplomatic expulsions since the Cold War, and relations between London and Moscow have since got even worse following Russia’s invasion of Ukraine.

    The Russian embassy in London said last week the British foreign ministry’s “references to the alleged use of the mythical Novichok are quite preposterous”.

    “Following the Salisbury provocation in 2018 it was the UK side that refused to follow established procedures and cooperate with Russia to uncover the truth,” it said on X.





    Source link

    Share this:

    • Click to share on Facebook (Opens in new window) Facebook
    • Click to share on X (Opens in new window) X

    Like this:

    Like Loading...

    Related

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleSelect Harvests (ASX:SHV) investors are sitting on a loss of 51% if they invested three years ago
    Next Article A Case for Broadening Retail Access to Private Markets
    user
    • Website

    Related Posts

    I bought 3,048 shares in this FTSE 250 high-yielder in 2023. Here’s how much dividend income I’ve had since…

    June 12, 2025

    Halma shares surge on outstanding results. But is there trouble ahead?

    June 12, 2025

    At a bargain-basement valuation now, is AstraZeneca’s share price impossible for me to ignore?

    June 12, 2025
    Add A Comment

    Leave a ReplyCancel reply

    © 2025 StockNews24. Designed by Sujon.

    Type above and press Enter to search. Press Esc to cancel.

    %d